Ticagrelor versus placebo to prevent delayed stroke after minor bleeding in the brain
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests whether the drug ticagrelor, which helps prevent blood clots, can reduce the risk of a stroke occurring days after a mild form of bleeding in the brain. It is given as an add-on to the standard treatment for the bleeding aneurysm.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You had a mild bleeding in the brain (doctors call this a low-grade subarachnoid hemorrhage).
- Your bleeding is from a small, balloon-like bulge on an artery (aneurysm) that will be treated within 72 hours.
- The aneurysm is planned to be treated with coils or similar minimally invasive methods (not stents or flow diverters).
- You are not currently taking any blood-thinning or antiplatelet medications.
- You do not have severe liver or kidney disease, active bleeding, or a recent major surgery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a medicine called tirofiban that helps prevent blood clots after a stent is placed to treat a burst brain aneurysm. The goal is to see if adding this medicine improves recovery and reduces the chance of another bleed.
This study tests a blood-thinning medicine called tirofiban to see if it helps reduce delayed brain damage after a type of stroke from a bleeding brain aneurysm. It is for people who have already had their aneurysm fixed with coiling, and the medicine is given soon after.
This trial tests whether switching to a simpler antiplatelet medication (ticagrelor) after a mild stroke or high-risk TIA can prevent another stroke while reducing the risk of bleeding. It is for people who have not received clot-busting treatment or had a large stroke.
This trial tests whether adding aspirin to either ticagrelor or clopidogrel (two antiplatelet medicines) can help prevent another stroke in people who recently had a minor stroke or TIA affecting a large brain artery. It is for people who started antiplatelet treatment within 24 hours of their symptoms.
This trial tests whether a common antiplatelet medicine can reduce the risk of future heart attacks, strokes, or blood clots in people who have had a brain bleed. It's for adults who had their first brain bleed and can start treatment within 3 months of the stroke.
This study compares two common blood-thinner combinations to see which one works better at preventing clots during stent placement for an unruptured brain aneurysm. It is designed for people whose bodies process these medications normally, with the goal of finding the safest and most effective option.
Hear when a new Brain Ischemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.